<DOC>
	<DOC>NCT00517309</DOC>
	<brief_summary>The primary purpose of the study is to test the safety of HPV Vaccine in Women</brief_summary>
	<brief_title>Study to Test the Safety of HPV Vaccine in Women (V501-011)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Condylomata Acuminata</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Females age 16 to 23 years old Must agree to refrain from sexual activity (vaginal or anal) for 48 hours prior to any scheduled visit History of vaccination with an HPV vaccine History of hepatitis B infection History of vaccination with hepatitis B vaccine History of genital warts or treatment for genital warts</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>23 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>